Platelet membrane fluidity and Na+/K+ ATPase activity in acute stroke

Brain Research

Volumn 1205, Issue , 2008, Pages 21-26

  Nanetti, Laura ^a   Vignini, Arianna ^a   Raffaelli, Francesca ^a   Moroni, Cinzia ^a   Silvestrini, Mauro ^a   Provinciali, Leandro ^a   Mazzanti, Laura ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Membrane fluidity; Na+ K+ ATPase; Platelets; Stroke

Indexed keywords

1 (4 TRIMETHYLAMINOPHENYL) 6 PHENYL 1,3,5 HEXATRIENE; 1,6 PHENYL 1,3,5 HEXATRIENE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); FLUORESCENT DYE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN DAMAGE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEMBRANE FLUIDITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SMOKING; STROKE; THROMBOCYTE MEMBRANE;

AGED; BLOOD PLATELETS; DIABETES MELLITUS; DIPHENYLHEXATRIENE; FEMALE; FLUORESCENT DYES; HUMANS; MALE; MEMBRANE FLUIDITY; MIDDLE AGED; PLATELET COUNT; RISK FACTORS; SMOKING; SODIUM-POTASSIUM-EXCHANGING ATPASE; STROKE; VASCULAR DISEASES;

EID: 41949136490     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.02.005     Document Type: Article

References (27)

1. Andrews R.K., Lopez J.A., and Berndt M.C. Molecular mechanisms of platelet adhesion and activation. Int. J. Biochem. Cell Biol. 29 (1997) 91-105
2. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteine-dye binding. Anal. Biochem. 72 (1976) 248-254
3. Caplan L.R. Antiplatelet therapy in stroke prevention: present and future. Cerebrovasc. Dis. 1 (2006) 1-6
4. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integral view. Trends Neurosci. 22 (1999) 391-397
5. Duportail G., and Weinreb A. Photochemical changes of fluorescent probes in membranes and their effect on the observed fluorescence anisotropy values. Biochim. Biophys. Acta. 736 2 (1983) 171-177
6. Fiske C., and Subbarow Y. The colorimetric determination of phpsphorus. J. Biol. Chem. 66 (1925) 375-400
7. Katsura K., Kristian T., and Siesjo B.K. Energy metabolism, ion homeostasis, and cell damage in the brain. Biochem. Soc. Trans. 22 4 (1994) 991-996
8. Kitao T., and Hattori K. Inhibition of erythrocyte ATPase activity by aclacinomycin and reverse effects of ascorbate on ATPase activity. Experientia 39 12 (1983) 1362-1364
9. Linfante I., and Akkawi N.M. Advances in treatment of acute ischemic stroke. Curr. Treat Options Neurol. 8 2 (2006) 159-165
10. Liu L., Lin Z., Shen Z., Zhang G., Li S., and Cao P. Platelets hyperfunction exists in both acute non-hemorrhagic and hemorrhagic stroke. Thromb. Res. 75 (1994) 485-490
11. Martin R.L., Lloyd H.G., and Cowan A.I. Cowan AI The early events of oxygen and glucose deprivation: setting the scene for neuronal death?. Trends Neurosci. 17 6 (1994) 251-257
12. Massberg S., Schurzinger K., Lorenz M., Konrad I., Schulz C., Plesnila N., Kennerknecht E., Rudelius M., Sauer S., Braun S., Kremmer E., Emambokus N.R., Frampton J., and Gawaz M. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation 112 8 (2005) 1180-1188
13. Mattson M.P., Duan W., Pedersen W.A., and Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6 1-2 (2001) 69-81
14. Mazzanti L., Rabini R.A., Salvolini E., Tesei M., Martarelli D., Venerando B., and Curatola G. Sialic acid, diabetes and aging: a study on the erythrocyte membrane. Metabolism 46 (1997) 59-61
15. Murray C.J., and Lopez A.D. Mortality by cause for eight regions of the word: Global burden of disease study. Lancet 349 (1997) 1269-1276
16. Rabini R.A., Vignini A., Martarelli D., Nanetti L., Salvolini E., Rizzo M.R., Ragno E., Paolisso G., Franceschi C., and Mazzanti L. Evidence for reduction of pro-atherosclerotic properties in platelets from healthy centenarians. Exp. Ger. 38 (2003) 367-371
17. Rao G.H.R. Measurement of ionized calcium in normal human blood platelets. Anal. Biochem. 169 (1988) 400-404
18. Sheridan N.P., and Block E.R. Plasma membrane fluidity measurements in intact endothelial cells: effect of hyperoxia on fluorescence anisotropies of 1-[4-(trimethylamino)phenyl]-6-phenyl hexa-1,3,5-triene. J. Cell Physiol. 134 1 (1988) 117-123
19. Siess W. Molecular mechanism of platelet activation. Physiol. Rev. 69 (1989) 58-178
20. Stys P.K. White matter injury mechanisms. Curr. Mol. Med. 4 2 (2004) 113-130
21. Tan K.T., and Lip G.Y. Platelet microparticles and platelet adhesion: therapeutic implications for the prevention and treatment of stroke. Curr. Treat Options Cardiovasc. Med. 8 3 (2006) 251-258
22. Toni D., Fiorelli M., Gentile M., Bastianello S., Sacchetti M.L., Argentino C., Pozzilli C., and Fieschi C. Pogressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis, and prognosis. Arc. Neurol. 52 (1995) 670-675
23. Van Swieten J.C., Koudstaal P.J., Visser M.C., et al. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19 (1988) 1083-1092
24. Wadley V.G., McClure L.A., Howard V.J., Unverzagt F.W., Go R.C., Moy C.S., Crowther M.R., Gomez C.R., and Howard G. Cognitive status, stroke symptom reports, and modifiable risk factors among individuals with no diagnosis of stroke or transient ischemic attack in the Reasons For Geographic And Racial Differences In Stroke (REGARDS) Study. Stroke 38 4 (2007) 1143-1147
25. Wityle R.J., Pessin M.S., Kaplan R.F., and Caplan L.R. Serial assessment of acute stroke using the NIH stroke scale. Stroke 25 (1994) 362-365
26. Yip H.K., Liou C.W., Chang H.W., Lan M.Y., Liu J.S., and Chen M.C. Link between platelet activity and outcomes after an ischemic stroke. Cerebrovasc. Dis. 20 2 (2005) 120-128
27. Zakim D. Interface between membrane biology and clinical medicine. Am. J. Med. 80 (1986) 645-647